Literature DB >> 20038818

mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes.

Chi Kwan Tsang1, Hui Liu, X F Steven Zheng.   

Abstract

Target of rapamycin (TOR) is a conserved regulator of gene expression from yeast to humans. In budding yeast, TOR is associated with ribosomal DNA (rDNA) promoter, which is critical for ribosome biogenesis and transfer RNA (tRNA) synthesis. Whether mTOR behaves similarly in mammalian cells is unknown. Here, we report that mTOR is detected at several different promoters in human and murine cells, including that of rDNA and tRNA genes. The association of mTOR with these promoters is regulated by growth signals and sensitive to rapamycin. Together, our observations suggest that mTOR is closely involved in gene regulation at the promoters, which is a conserved mechanism to control RNA polymerase I- and III-dependent genes that are critical for protein synthesis and cell growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20038818      PMCID: PMC3023410          DOI: 10.4161/cc.9.5.10876

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  32 in total

Review 1.  The economics of ribosome biosynthesis in yeast.

Authors:  J R Warner
Journal:  Trends Biochem Sci       Date:  1999-11       Impact factor: 13.807

2.  Mechanisms of regulation of RNA polymerase III-dependent transcription by TORC1.

Authors:  Yuehua Wei; Chi Kwan Tsang; X F Steven Zheng
Journal:  EMBO J       Date:  2009-07-02       Impact factor: 11.598

3.  Cell biology. RNA metabolism and oncogenesis.

Authors:  Deborah L Johnson; Sandra A S Johnson
Journal:  Science       Date:  2008-04-25       Impact factor: 47.728

4.  TORC1 association with rDNA chromatin as a mechanism to co-regulate Pol I and Pol III.

Authors:  Yuehua Wei; X F Steven Zheng
Journal:  Cell Cycle       Date:  2009-12       Impact factor: 4.534

5.  Early pre-implantation lethality in mice carrying truncated mutation in the RNA polymerase 1-2 gene.

Authors:  Hui Chen; Zhenghua Li; Kyoko Haruna; Zhengzhe Li; Zhongzhe Li; Kei Semba; Masatake Araki; Ken-Ichi Yamamura; Kimi Araki
Journal:  Biochem Biophys Res Commun       Date:  2007-11-20       Impact factor: 3.575

6.  Sch9 partially mediates TORC1 signaling to control ribosomal RNA synthesis.

Authors:  Yuehua Wei; X F Steven Zheng
Journal:  Cell Cycle       Date:  2009-12-25       Impact factor: 4.534

7.  Regulation of RNA polymerase III transcription by Maf1 in mammalian cells.

Authors:  Sarah J Goodfellow; Emma L Graham; Theodoros Kantidakis; Lynne Marshall; Beverly A Coppins; Danuta Oficjalska-Pham; Matthieu Gérard; Olivier Lefebvre; Robert J White
Journal:  J Mol Biol       Date:  2008-03-04       Impact factor: 5.469

8.  mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.

Authors:  John T Cunningham; Joseph T Rodgers; Daniel H Arlow; Francisca Vazquez; Vamsi K Mootha; Pere Puigserver
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

9.  PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex.

Authors:  Annette Woiwode; Sandra A S Johnson; Shuping Zhong; Cheng Zhang; Robert G Roeder; Martin Teichmann; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

10.  Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation.

Authors:  Lynne Marshall; Niall S Kenneth; Robert J White
Journal:  Cell       Date:  2008-04-04       Impact factor: 41.582

View more
  72 in total

1.  mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1.

Authors:  Theodoros Kantidakis; Ben A Ramsbottom; Joanna L Birch; Sarah N Dowding; Robert J White
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-11       Impact factor: 11.205

2.  mTORC1 directly phosphorylates and regulates human MAF1.

Authors:  Annemieke A Michels; Aaron M Robitaille; Diane Buczynski-Ruchonnet; Wassim Hodroj; Jaime H Reina; Michael N Hall; Nouria Hernandez
Journal:  Mol Cell Biol       Date:  2010-06-01       Impact factor: 4.272

3.  The expanding relevance of nuclear mTOR in carcinogenesis.

Authors:  Jung H Back; Arianna L Kim
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

4.  SHPRH regulates rRNA transcription by recognizing the histone code in an mTOR-dependent manner.

Authors:  Deokjae Lee; Jungeun An; Young-Un Park; Hungjiun Liaw; Roger Woodgate; Jun Hong Park; Kyungjae Myung
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-11       Impact factor: 11.205

5.  mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.

Authors:  Rafik Boudra; Rosyne Lagrafeuille; Corinne Lours-Calet; Cyrille de Joussineau; Gaëlle Loubeau-Legros; Cédric Chaveroux; Jean-Paul Saru; Silvère Baron; Laurent Morel; Claude Beaudoin
Journal:  Cell Cycle       Date:  2016-05-18       Impact factor: 4.534

Review 6.  Cell growth- and differentiation-dependent regulation of RNA polymerase III transcription.

Authors:  Hélène Dumay-Odelot; Stéphanie Durrieu-Gaillard; Daniel Da Silva; Robert G Roeder; Martin Teichmann
Journal:  Cell Cycle       Date:  2010-09-01       Impact factor: 4.534

Review 7.  Regulation of Ribosome Biogenesis in Skeletal Muscle Hypertrophy.

Authors:  Vandré Casagrande Figueiredo; John J McCarthy
Journal:  Physiology (Bethesda)       Date:  2019-01-01

Review 8.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 9.  Transcriptional and Epigenetic Regulation by the Mechanistic Target of Rapamycin Complex 1 Pathway.

Authors:  R Nicholas Laribee
Journal:  J Mol Biol       Date:  2018-10-23       Impact factor: 5.469

10.  A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy.

Authors:  Craig A Goodman; Man Hing Miu; John W Frey; Danielle M Mabrey; Hannah C Lincoln; Yejing Ge; Jie Chen; Troy A Hornberger
Journal:  Mol Biol Cell       Date:  2010-07-28       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.